Page 1 of Clinical Trials for Prologue Research International [SPONSOR-COLLABORATORS], 14 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer
Last Updated: March 29, 2011
Condition(s): Colorectal Cancer
2
Completed
Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer
Last Updated: December 18, 2010
Condition(s): Colorectal Cancer
3
Completed
Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer
Last Updated: December 18, 2010
Condition(s): Colorectal Cancer
4
Completed
Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer
Last Updated: February 15, 2011
Condition(s): Colorectal Cancer Metastatic
5
Completed
Study of the Combination of Lenalidomide and DTIC (Dacarbazine) in Patients With Metastatic Malignant Melanoma Previously Untreated With Systemic Chemotherapy
Last Updated: January 8, 2010
Condition(s): Malignant Melanoma
6
Completed
Study of Lenalidomide With Topotecan In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma
Last Updated: December 19, 2006
Condition(s): Ovarian Cancer
7
Terminated
Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid® CC-5013) With Liposomal Doxorubicin In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma
Last Updated: April 10, 2006
Condition(s): Ovarian Cancer
8
Terminated
A Multicenter, Single-Arm, Open-Label, Study to Evaluate the Safety and Efficacy of Single-Agent Lenalidomide (Revlimid, CC-5013) in Subjects With Androgen Independent Prostate Cancer.
Last Updated: November 22, 2005
Condition(s): Prostate Cancer
9
Completed
Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple Myeloma
Last Updated: March 10, 2010
Condition(s): Multiple Myeloma
10
Terminated
A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcinoma of the Pancreas
Last Updated: November 2, 2005
Condition(s): Pancreatic Cancer
11
Completed
Safety And Efficacy In Subjects With Relapsed Or Refractory Aggressive Non-Hodgkin’s Lymphoma
Last Updated: November 29, 2006
Condition(s): Non-Hodgkins Lymphoma
12
Completed
Lenalidomide (Revlimid®, CC-5013) in Subjects With Relapsed or Refractory Indolent Non-Hodgkin’s Lymphoma
Last Updated: November 30, 2006
Condition(s): Non-Hodgkins Lymphoma
13
Completed
A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung Cancer
Last Updated: December 19, 2006
Condition(s): Non-Small Cell Lung Cancer
14
Terminated
Phase I Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile Of Lenalidomide (Revlimid®, CC-5013) With Pemetrexed In Subjects With Advanced Non-Small Cell Lung Cancer
Last Updated: November 2, 2005
Condition(s): Non-Small Cell Lung Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Prologue+Research+International

Page 1 of Clinical Trials for Prologue Research International [SPONSOR-COLLABORATORS], 14 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About